
Psyence BioMed Invested in PsyLabs for Texas Trial
The firm committed $5 million and initiated a share exchange to support clinical trials for pharmaceutical-grade ibogaine.
Live Poll
Should pharmaceutical companies prioritize the development and manufacturing of experimental drugs for clinical research?






